<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05042232</url>
  </required_header>
  <id_info>
    <org_study_id>EW-US-4010-0003</org_study_id>
    <nct_id>NCT05042232</nct_id>
  </id_info>
  <brief_title>A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19</brief_title>
  <official_title>Assessing Behavioral, Functional, and Clinical Patient-Reported Outcomes (PROs) in Subjects Diagnosed With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Everly Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Everly Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to identify and describe patient behaviors and&#xD;
      clinical outcomes among patients who have tested positive for mild to moderate COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This virtual observational cohort study will describe patient behaviors and clinical outcomes&#xD;
      of subjects who tested positive for COVID-19. Among those with positive tests, predictors of&#xD;
      time to recovery, post-COVID function and outcomes will be identified. Individuals who test&#xD;
      negative and positive for SARS-CoV-2 will be enrolled in the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify and describe patient behaviors and clinical outcomes among patients who have tested positive for COVID-19</measure>
    <time_frame>Up to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To describe recovery in patients with test-confirmed COVID-19 infection including time to recovery and functional improvement</measure>
    <time_frame>Up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To develop prediction tools for time to recovery, function and outcomes in patients with COVID-19 identified by home testing</measure>
    <time_frame>Up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe users and the utilization of COVID-19 home testing over time by geography, demographics, and comorbidity</measure>
    <time_frame>Up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the feasibility of COVID-19 home testing</measure>
    <time_frame>Up to 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>SARS-CoV-2 Acute Respiratory Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SARS-CoV-2 Positive</intervention_name>
    <description>Participants who have tested positive for SARS-CoV-2, both with and without symptoms</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SARS-CoV-2 Negative</intervention_name>
    <description>Participants who have tested negative for SARS-CoV-2</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals who have valid COVID-19 test results.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;=18 years&#xD;
&#xD;
          -  Individuals with a valid diagnostic COVID-19 test result&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Unable or unwilling to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Bauer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Everly Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Divya Guthikonda</last_name>
    <phone>737-787-2560</phone>
    <email>infoclinscience@everlywell.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Everlywell, Inc</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Divay Guthikonda</last_name>
      <phone>737-787-2560</phone>
      <email>infoclinscience@everlywell.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

